Advancing cellular therapies: moving beyond the CAR-T landscape

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Frank Borriello, Founder and CEO, Alloplex Biotherapeutics, to discuss the challenges the I-O landscape faces in the cellular therapy landscape and the advantages that Alloplex’s lead platform ‘SUPLEXA cells’ have in overcoming these challenges.

Please enter your email to access content Read now